Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis

BACKGROUND AND OBJECTIVES: The University of California Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0 (UCLA GIT 2.0) is validated to capture gastrointestinal (GI) tract morbidity in patients with systemic sclerosis (SSc). The aims of this study were to deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Zampatti, Norina, Garaiman, Alexandru, Jordan, Suzana, Dobrota, Rucsandra, Becker, Mike Oliver, Maurer, Britta, Distler, Oliver, Mihai, Carina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061014/
https://www.ncbi.nlm.nih.gov/pubmed/33888149
http://dx.doi.org/10.1186/s13075-021-02506-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061014/
https://www.ncbi.nlm.nih.gov/pubmed/33888149
http://dx.doi.org/10.1186/s13075-021-02506-x

Ejemplares similares